Table of Contents Table of Contents
Previous Page  592 / 1726 Next Page
Information
Show Menu
Previous Page 592 / 1726 Next Page
Page Background

GUSTAVE ROUSSY

THÈME DU DIAPORAMA

RTOG-0724

Lead Group:

RTOG

SWOG

NSABP

NCIC

NCCTG

GOG

ECOG

CALGB

ACOSOG

POST-OP HIGH RISK CERVICAL

CANCERS:

Phase III Randomized Study of

Concurrent Chemotherapy and Pelvic RT

With or Without Adjuvant (Pacli + Carbo

every 21 days x 4 cycles) Chemotherapy in

High-Risk Patients with Early-Stage Cervical

Carcinoma Following Radical Hysterectomy

To Date:

163

Target:

400

(09/15/14)

GOG-0263

Lead Group:

GOG

SWOG

RTOG

NSABP

NCIC

NCCTG

ECOG

CALGB

ACOSOG

POST-OP INTERMEDIATE RISK CERVICAL

CANCERS:

Randomized Phase III Clinical

Trial of Adjuvant Radiation Versus Chemo-

radiation in Intermediate Risk, Stage I/IIA

Cervical Cancer Treated with Initial Radical

Hysterectomy and Pelvic LND dissection

Target:

534

Ongoing studies